SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A slight decline in the revenue of Rs. 12643.00 millions was seen for the September 2025 quarter as against Rs. 12926.00 millions during year-ago period.The Company's Net profit for the September 2025 quarter have declined marginally to Rs. 5009.00  millions as against Rs. 6611.00 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 6458.00 millions from 8421.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 12643.00 12926.00 -2.19 24570.00 25295.00 -2.87 40945.00 35689.00 14.73
Other Income 933.00 514.00 81.52 1529.00 912.00 67.65 3213.00 1047.00 206.88
PBIDT 6458.00 8421.00 -23.31 12451.00 16449.00 -24.31 24656.00 17417.00 41.56
Interest 117.00 30.00 290.00 143.00 74.00 93.24 196.00 145.00 35.17
PBDT 6341.00 8391.00 -24.43 12308.00 16375.00 -24.84 24460.00 17272.00 41.62
Depreciation 481.00 422.00 13.98 1019.00 826.00 23.37 2200.00 1719.00 27.98
PBT 5860.00 7969.00 -26.47 11289.00 15549.00 -27.40 22260.00 15553.00 43.12
TAX 851.00 1358.00 -37.33 1639.00 2575.00 -36.35 3756.00 2487.00 51.03
Deferred Tax -455.00 -120.00 279.17 -727.00 -227.00 220.26 -319.00 -361.00 -11.63
PAT 5009.00 6611.00 -24.23 9650.00 12974.00 -25.62 18504.00 13066.00 41.62
Equity 358.00 358.00 0.00 358.00 358.00 0.00 358.00 358.00 0.00
PBIDTM(%) 51.08 65.15 -21.59 50.68 65.03 -22.07 60.22 48.80 23.39

Natco Pharma Share Price

1174.00 19.80 (1.72%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×